🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 005329107
- Market Cap
- Large Cap
- IPO
- 2/9/2021 · $19.00/share
- ADR Ratio
- 1:1.25
Business: Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs.
Company Contact
- CEO
- Peter (Peizhi) Luo
- CFO
- Raymond Tam
- Investor Relations
- IR@adagene.com